Disruption of the serotonergic system after neonatal hypoxia-ischemia in a rodent model

Neurology Research International

Volumn 2012, Issue , 2012, Pages

  Buller, Kathryn M ^a   Wixey, Julie A ^a   Reinebrant, Hanna E ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866167943     PISSN: 20901852     EISSN: 20901860     Source Type: Journal    
DOI: 10.1155/2012/650382     Document Type: Review

References (165)

1. Volpe J. J., Brain injury in the premature infant: neuropathology, clinical aspects, and pathogenesis. Mental Retardation and Developmental Disabilities Research Reviews 1997 3 1 3 12 2-s2.0-0030890213 10.1002/(SICI)1098-2779(1997)3:13::AID-MRDD2>3.0.CO;2-U (Pubitemid 27190667)
2. Volpe J. J., Neurobiology of periventricular leukomalacia in the premature infant. Pediatric Research 2001 50 5 553 562 2-s2.0-0034770283 (Pubitemid 33009976)
3. Larroque B., Ancel P. Y., Marret S., Marchand L., André M., Arnaud C., Pierrat V., Rozé J. C., Messer J., Thiriez G., Burguet A., Picaud J. C., Bréart G., Kaminski M., Neurodevelopmental disabilities and special care of 5-year-old children born before 33 weeks of gestation (the EPIPAGE study): a longitudinal cohort study. The Lancet 2008 371 9615 813 820 2-s2.0-40049098369 10.1016/S0140-6736(08)60380-3 (Pubitemid 351330166)
4. Peterson B. S., Anderson A. W., Ehrenkranz R., Staib L. H., Tageldin M., Colson E., Gore J. C., Duncan C. C., Makuch R., Ment L. R., Regional brain volumes and their later neurodevelopmental correlates in term and preterm infants. Pediatrics 2003 111 5 939 948 2-s2.0-0038185305 10.1542/peds.111.5.939 (Pubitemid 36542604)
5. Anderson P., Doyle L. W., Neurobehavioral outcomes of school-age children born extremely low birth weight or very preterm in the 1990s. Journal of the American Medical Association 2003 289 24 3264 3272 2-s2.0-0038167818 10.1001/jama.289.24.3264 (Pubitemid 37430079)
6. O'Brien F., Roth S., Stewart A., Rifkin L., Rushe T., Wyatt J., The neurodevelopmental progress of infants less than 33 weeks into adolescence. Archives of Disease in Childhood 2004 89 3 207 211 2-s2.0-1542377378 10.1136/adc.2002.006676 (Pubitemid 38325807)
7. Hack M., Youngstrom E. A., Cartar L., Schluchter M., Gerry Taylor H., Flannery D., Klein N., Borawski E., Behavioral outcomes and evidence of psychopathology among very low birth weight infants at age 20 years. Pediatrics 2004 114 4 932 940 2-s2.0-16644376568 10.1542/peds.2003-1017-L (Pubitemid 41529755)
8. Logitharajah P., Rutherford M. A., Cowan F. M., Hypoxic-ischemic encephalopathy in preterm infants: antecedent factors, brain imaging, and outcome. Pediatric Research 2009 66 2 222 229 2-s2.0-70349898726 10.1203/PDR.0b013e3181a9ef34
9. Selway L. D., State of the science: hypoxic ischemic encephalopathy and hypothermic intervention for neonates. Advances in Neonatal Care 2010 10 2 60 66 2-s2.0-77952267258
10. Pfister R. H., Soll R. F., Hypothermia for the treatment of infants with hypoxic-ischemic encephalopathy. Journal of Perinatology 2010 30 1 S82 S87 2-s2.0-77957550493 10.1038/jp.2010.91
11. Pierson C. R., Folkerth R. D., Billiards S. S., Trachtenberg F. L., Drinkwater M. E., Volpe J. J., Kinney H. C., Gray matter injury associated with periventricular leukomalacia in the premature infant. Acta Neuropathologica 2007 114 6 619 631 2-s2.0-36348940550 10.1007/s00401-007-0295-5 (Pubitemid 350142750)
12. Volpe J. J., Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. The Lancet Neurology 2009 8 1 110 124 2-s2.0-57149118216 10.1016/S1474-4422(08)70294-1
13. Leviton A., Gressens P., Neuronal damage accompanies perinatal white-matter damage. Trends in Neurosciences 2007 30 9 473 478 2-s2.0-34548512545 10.1016/j.tins.2007.05.009 (Pubitemid 47374834)
14. Billiards S. S., Haynes R. L., Folkerth R. D., Trachtenberg F. L., Liu L. G., Volpe J. J., Kinney H. C., Development of microglia in the cerebral white matter of the human fetus and infant. Journal of Comparative Neurology 2006 497 2 199 208 2-s2.0-33744740398 10.1002/cne.20991 (Pubitemid 43825427)
15. Haynes R. L., Folkerth R. D., Keefe R. J., Sung I., Swzeda L. I., Rosenberg P. A., Volpe J. J., Kinney H. C., Nitrosative and oxidative injury to premyelinating oligodendrocytes in periventricular leukomalacia. Journal of Neuropathology and Experimental Neurology 2003 62 5 441 450 2-s2.0-0037651981 (Pubitemid 36560186)
16. Nosarti C., Rushe T. M., Woodruff P. W. R., Stewart A. L., Rifkin L., Murray R. M., Corpus callosum size and very preterm birth: relationship to neuropsychological outcome. Brain 2004 127 9 2080 2089 2-s2.0-4344593758 10.1093/brain/awh230 (Pubitemid 39150265)
17. Inder T. E., Huppi P. S., Warfield S., Kikinis R., Zientara G. P., Barnes P. D., Jolesz F., Volpe J. J., Periventricular white matter injury in the premature infant is followed by reduced cerebral cortical gray matter volume at term. Annals of Neurology 1999 46 5 755 760 2-s2.0-0032704516 10.1002/1531-8249(199911)46:5755::AID-ANA11>3.0.CO;2-0 (Pubitemid 29518137)
18. Ricci D., Anker S., Cowan F., Pane M., Gallini F., Luciano R., Donvito V., Baranello G., Cesarini L., Bianco F., Rutherford M., Romagnoli C., Atkinson J., Braddick O., Guzzetta F., Mercuri E., Thalamic atrophy in infants with PVL and cerebral visual impairment. Early Human Development 2006 82 9 591 595 2-s2.0-33747877989 10.1016/j.earlhumdev.2005.12.007 (Pubitemid 44293163)
19. Peterson B. S., Vohr B., Staib L. H., Cannistraci C. J., Dolberg A., Schneider K. C., Katz K. H., Westerveld M., Sparrow S., Anderson A. W., Duncan C. C., Makuch R. W., Gore J. C., Ment L. R., Regional brain volume abnormalities and long-term cognitive outcome in preterm infants. Journal of the American Medical Association 2000 284 15 1939 1947 2-s2.0-0034684151
20. Kesler S. R., Ment L. R., Vohr B., Pajot S. K., Schneider K. C., Katz K. H., Ebbitt T. B., Duncan C. C., Makuch R. W., Reiss A. L., Volumetric analysis of regional cerebral development in preterm children. Pediatric Neurology 2004 31 5 318 325 2-s2.0-7044262244 10.1016/j.pediatrneurol.2004.06.008 (Pubitemid 39424196)
21. Zubiaurre-Elorza L., Soria-Pastor S., Junque C., cjunque@ub.edu Segarra D., Bargalló N., Mayolas N., Romano-Berindoague C., MacAya A., Gray matter volume decrements in preterm children with periventricular leukomalacia. Pediatric Research 2011 69 6 554 560 10.1203/PDR.0b013e3182182366
22. Haynes R. L., Billiards S. S., Borenstein N. S., Volpe J. J., Kinney H. C., Diffuse axonal injury in periventricular leukomalacia as determined by apoptotic marker fractin. Pediatric Research 2008 63 6 656 661 2-s2.0-45849133831 10.1203/PDR.0b013e31816c825c
23. Larouche A., Roy M., Kadhim H., Tsanaclis A. M., Fortin D., Sébire G., Neuronal injuries induced by perinatal hypoxic-ischemic insults are potentiated by prenatal exposure to lipopolysaccharide: animal model for perinatally acquired encephalopathy. Developmental Neuroscience 2005 27 24 134 142 2-s2.0-23244449096 10.1159/000085985 (Pubitemid 41096219)
24. Marín-Padilla M., Developmental neuropathology and impact of perinatal brain damage. III: gray matter lesions of the neocortex. Journal of Neuropathology and Experimental Neurology 1999 58 5 407 429 (Pubitemid 29220735)
25. Nakajima W., Ishida A., Lange M. S., Gabrielson K. L., Wilson M. A., Martin L. J., Blue M. E., Johnston M. V., Apoptosis has a prolonged role in the neurodegeneration after hypoxic ischemia in the newborn rat. Journal of Neuroscience 2000 20 21 7994 8004 2-s2.0-0034329279
26. Northington F. J., Ferriero D. M., Flock D. L., Martin L. J., Delayed neurodegeneration in neonatal rat thalamus after hypoxia-ischemia is apoptosis. Journal of Neuroscience 2001 21 6 1931 1938 2-s2.0-0035869339 (Pubitemid 32221377)
27. Oo T. F., Henchcliffe C., Burke R. E., Apoptosis in substantia nigra following developmental hypoxic-ischemic injury. Neuroscience 1995 69 3 893 901 2-s2.0-0028784719 10.1016/0306-4522(95)00282-N
28. Buller K. M., Wixey J. A., Pathipati P., Carty M., Colditz P. B., Williams C. E., Scheepens A., Selective losses of brainstem catecholamine neurons after hypoxia-ischemia in the immature rat pup. Pediatric Research 2008 63 4 364 369 2-s2.0-41349122943 10.1203/PDR.0b013e3181659774 (Pubitemid 351450580)
29. Loidl C. F., Herrera-Marschitz M., Andersson K., You Z. B., Goiny M., O'Connor W. T., Silveira R., Rawal R., Bjelke B., Chen Y., Ungerstedt U., Long-term effects of perinatal asphyxia on basal ganglia neurotransmitter systems studied with microdialysis in rat. Neuroscience Letters 1994 175 1-2 9 12 2-s2.0-0028304250 10.1016/0304-3940(94)91065-0 (Pubitemid 24215472)
30. Johnston M. V., Hudson C., Effects of postnatal hypoxia-ischemia on cholinergic neurons in the developing rat forebrain: choline acetyltransferase immunocytochemistry. Brain Research 1987 431 1 41 50 2-s2.0-0023376774 (Pubitemid 17112932)
31. Allen G. V., Cheung R. T. F., Cechetto D. F., Neurochemical changes following occlusion of the middle cerebral artery in rats. Neuroscience 1995 68 4 1037 1050 2-s2.0-0029123305 10.1016/0306-4522(95)00198-R
32. Kohlhauser C., Kaehler S., Mosgoeller W., Singewald N., Kouvelas D., Prast H., Hoeger H., Lubec B., Histological changes and neurotransmitter levels three months following perinatal asphyxia in the rat. Life Sciences 1999 64 23 2109 2124 2-s2.0-0033617411 10.1016/S0024-3205(99)00160-5 (Pubitemid 29236571)
33. Herlenius E., Lagercrantz H., Development of neurotransmitter systems during critical periods. Experimental Neurology 2004 190 1 S8 S21 2-s2.0-7544241660 10.1016/j.expneurol.2004.03.027 (Pubitemid 39451785)
34. Currás-Collazo M. C., Patel U. B., Hussein M. O., Reduced susceptibility of magnocellular neuroendocrine nuclei of the rat hypothalamus to transient focal ischemia produced by middle cerebral artery occlusion. Experimental Neurology 2002 178 2 268 279 10.1006/exnr.2002.8032 (Pubitemid 36062636)
35. Gross J., Müller I., Chen Y., Elizalde M., Leclere N., Herrera-Marschitz M., Andersson K., Perinatal asphyxia induces region-specific long-term changes in mRNA levels of tyrosine hydroxylase and dopamine D1 and D2 receptors in rat brain. Molecular Brain Research 2000 79 1-2 110 117 2-s2.0-0343628778 10.1016/S0169-328X(00)00106-6 (Pubitemid 30495534)
36. Cheung R. T. F., Cechetto D. F., Colchicine affects cortical and amygdalar neurochemical changes differentially after middle cerebral artery occlusion in rats. Journal of Comparative Neurology 1997 387 1 27 41 2-s2.0-0030883978 10.1002/(SICI)1096-9861(19971013)387:127::AID-CNE3>3.0. CO;2-P (Pubitemid 27419457)
37. Gaspar P., Cases O., Maroteaux L., The developmental role of serotonin: news from mouse molecular genetics. Nature Reviews Neuroscience 2003 4 12 1002 1012 2-s2.0-0345258497 (Pubitemid 37486676)
38. Gartside S. E., Johnson D. A., Leitch M. M., Troakes C., Ingram C. D., Early life adversity programs changes in central 5-HT neuronal function in adulthood. European Journal of Neuroscience 2003 17 11 2401 2408 2-s2.0-0038729379 10.1046/j.1460-9568.2003.02668.x (Pubitemid 36793748)
39. Gardner K. L., Thrivikraman K. V., Lightman S. L., Plotsky P. M., Lowry C. A., Early life experience alters behavior during social defeat: focus on serotonergic systems. Neuroscience 2005 136 1 181 191 2-s2.0-26944497596 10.1016/j.neuroscience.2005.07.042 (Pubitemid 41483846)
40. Lowry C. A., Johnson P. L., Hay-Schmidt A., Mikkelsen J., Shekhar A., Modulation of anxiety circuits by serotonergic systems. Stress 2005 8 4 233 246 2-s2.0-31544450567 10.1080/10253890500492787 (Pubitemid 43163256)
41. Duncan J. R., Paterson D. S., Hoffman J. M., Mokler D. J., Borenstein N. S., Belliveau R. A., Krous H. F., Haas E. A., Stanley C., Nattie E. E., Trachtenberg F. L., Kinney H. C., Brainstem serotonergic deficiency in sudden infant death syndrome. Journal of the American Medical Association 2010 303 5 430 437 2-s2.0-75849163495 10.1001/jama.2010.45
42. Nemeroff C. B., Owens M. J., The role of serotonin in the pathophysiology of depression: as important as ever. Clinical Chemistry 2009 55 8 1578 1579 2-s2.0-68149171355 10.1373/clinchem.2009.123752
43. Pardo C. A., Eberhart C. G., The neurobiology of autism. Brain Pathology 2007 17 4 434 447 2-s2.0-35148839591 10.1111/j.1750-3639.2007.00102.x (Pubitemid 47537607)
44. Ferriero D. M., Neonatal brain injury. The New England Journal of Medicine 2004 351 1985 1995
45. Baumann B., Bielau H., Krell D., Agelink M. W., Diekmann S., Wurthmann C., Trübner K., Bernstein H. G., Danos P., Bogerts B., Circumscribed numerical deficit of dorsal raphe neurons in mood disorders. Psychological Medicine 2002 32 1 93 103 2-s2.0-0036133509 (Pubitemid 33150506)
46. Rone L. A., Ferrando S. J., Serotonin reuptake inhibitor-related extrapyramidal side effects in two patients with cerebral palsy. Psychosomatics 1996 37 2 165 166 2-s2.0-0030021190 (Pubitemid 26066262)
47. Krakovsky G., Huth M. M., Lin L., Levin R. S., Functional changes in children, adolescents, and young adults with cerebral palsy. Research in Developmental Disabilities 2007 28 4 331 340 2-s2.0-34249310547 10.1016/j.ridd.2006.03.005 (Pubitemid 46810190)
48. Hagberg H., Peebles D., Mallard C., Models of white matter injury: comparison of infectious, hypoxic-Ischemic, and excitotoxic insults. Mental Retardation and Developmental Disabilities Research Reviews 2002 8 1 30 38 2-s2.0-0036309487 10.1002/mrdd.10007 (Pubitemid 34754491)
49. Back S. A., Luo N. L., Borenstein N. S., Levine J. M., Volpe J. J., Kinney H. C., Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. Journal of Neuroscience 2001 21 4 1302 1312 2-s2.0-0035866062 (Pubitemid 32128775)
50. Carty M. L., Wixey J. A., Colditz P. B., Buller K. M., Post-insult minocycline treatment attenuates hypoxia-ischemia-induced neuroinflammation and white matter injury in the neonatal rat: a comparison of two different dose regimens. International Journal of Developmental Neuroscience 2008 26 5 477 485 2-s2.0-43049181767 10.1016/j.ijdevneu.2008.02.005
51. Sizonenko S. V., Kiss J. Z., Inder T., Gluckman P. D., Williams C. E., Distinctive neuropathologic alterations in the deep layers of the parietal cortex after moderate ischemic-hypoxic injury in the P3 immature rat brain. Pediatric Research 2005 57 6 865 872 2-s2.0-19444378509 10.1203/01.PDR. 0000157673.36848.67 (Pubitemid 40727119)
52. Walther D. J., Peter J. U., Bashammakh S., Hörtnagl H., Voits M., Fink H., Bader M., Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 2003 299 5603 76 2-s2.0-0037414862 10.1126/science.1078197 (Pubitemid 36042402)
53. Blakely R. D., Berson H. E., Fremeau R. T., Caron M. G., Peek M. M., Prince H. K., Bradley C. C., Cloning and expression of a functional serotonin transporter from rat brain. Nature 1991 353 6348 66 70 2-s2.0-0026419334 (Pubitemid 21896784)
54. Dahlström A., Fuxe K., Localization of monoamines in the lower brain stem. Experientia 1964 20 7 398 399 2-s2.0-0013774096 10.1007/BF02147990
55. Hornung J. P., The human raphe nuclei and the serotonergic system. Journal of Chemical Neuroanatomy 2003 26 4 331 343 2-s2.0-0346023036 10.1016/j.jchemneu.2003.10.002 (Pubitemid 38077156)
56. Kinney H. C., Hannah.kinney@childrens.harvard.edu Broadbelt K. G., Haynes R. L., Rognum I. J., Paterson D. S., The serotonergic anatomy of the developing human medulla oblongata: implications for pediatric disorders of homeostasis. Journal of Chemical Neuroanatomy 2011 41 4 182 199 10.1016/j.jchemneu.2011.05. 004
57. Hayashi M., Itoh M., Araki S., Kumada S., Tanuma N., Kohji T., Kohyama J., Iwakawa Y., Satoh J., Morimatsu Y., Immunohistochemical analysis of brainstem lesions in infantile spasms. Neuropathology 2000 20 4 297 303 2-s2.0-0034493218 10.1046/j.1440-1789.2000.00353.x (Pubitemid 32125546)
58. Reinebrant H. E., Wixey J. A., Gobe G. C., Colditz P. B., Buller K. M., Differential effects of neonatal hypoxic-ischemic brain injury on brainstem serotonergic raphe nuclei. Brain Research 2010 1322 124 133 2-s2.0-77649235502 10.1016/j.brainres.2010.01.065
59. Takeuchi Y., Fujiwara K., Ishimura K., Aoki S., Okano S., Yamazoe I., Yoshioka H., Sawada T., Effects of neonatal asphyxlia on the serotonin neuron system in the developing brain studied by immunohistochemistry. Developmental Neuroscience 1992 14 5-6 394 402 2-s2.0-0027007676 (Pubitemid 23124850)
60. Shiraishi M., Takizawa Y., Ide S., Obonai T., Goto Y. I., Itoh M., Brainstem monoamine pathology of neonatal hypoxic-ischemic brain damage: a model of acute stage of neonatal asphyxia. Brain Research 2008 1213 120 126 2-s2.0-44449085256 10.1016/j.brainres.2008.03.068
61. Kosofsky B. E., Molliver M. E., The serotoninergic innervation of cerebral cortex: different classes of axon terminals arise from dorsal and median raphe nuclei. Synapse 1987 1 2 153 168 2-s2.0-0023188704 (Pubitemid 17119662)
62. Michelsen K. A., Schmitz C., Steinbusch H. W. M., The dorsal raphe nucleus-from silver stainings to a role in depression. Brain Research Reviews 2007 55 2 329 342 2-s2.0-34547749076 10.1016/j.brainresrev.2007.01.002 (Pubitemid 47554453)
63. Bowker R. M., Westlund K. N., Coulter J. D., Origins of serotonergic projections to the spinal cord in rat: an immunocytochemical-retrograde transport study. Brain Research 1981 226 1-2 187 199 2-s2.0-0019837585 (Pubitemid 12193715)
64. Clancy R. R., Stadky J. T., Rorke L. B., Hypoxic-ischemic spinal cord injury following perinatal asphyxia. Annals of Neurology 1989 25 2 185 189 2-s2.0-0024571344 (Pubitemid 19051253)
65. Groenendaal F., Vles J., Lammers H., De Vente J., Smit D., Nikkels P. G. J., Nitrotyrosine in human neonatal spinal cord after perinatal asphyxia. Neonatology 2008 93 1 1 6 2-s2.0-37249081083 10.1159/000106432 (Pubitemid 350277287)
66. Hadjiconstantinou M., Yates A. J., Neff N. H., Hypoxia-induced neurotransmitter deficits in neonatal rats are partially corrected by exogenous GM1 ganglioside. Journal of Neurochemistry 1990 55 3 864 869 2-s2.0-0025038287 10.1111/j.1471-4159.1990.tb04571.x (Pubitemid 20274352)
67. Wixey J. A., Reinebrant H. E., Buller K. M., Inhibition of neuroinflammation prevents injury to the serotonergic network after hypoxia-ischemia in the immature rat brain. Journal of Neuropathology and Experimental Neurology 2011 70 1 23 35 2-s2.0-78650678714 10.1097/NEN. 0b013e3182020b7b
68. Wixey J. A., Reinebrant H. E., Spencer S. J., Buller K. M., k.buller@uq.edu.au Efficacy of post-insult minocycline administration to alter long-term hypoxia-ischemia-induced damage to the serotonergic system in the immature rat brain. Neuroscience 2011 182 184 192 10.1016/j.neuroscience.2011. 03.033
69. Zhou F. C., Tao-Cheng J. H., Segu L., Patel T., Wang Y., Serotonin transporters are located on the axons beyond the synaptic junctions: anatomical and functional evidence. Brain Research 1998 805 1-2 241 254 2-s2.0-0032517176 10.1016/S0006-8993(98)00691-X (Pubitemid 29005140)
70. Smith H. R., Porrino L. J., The comparative distributions of the monoamine transporters in the rodent, monkey, and human amygdala. Brain Structure and Function 2008 213 1-2 73 91 2-s2.0-50249124747 10.1007/s00429-008-0176-2
71. Yamamoto H., Fujimiya M., Shirai Y., Nakashita M., Oyasu M., Saito N., Immunohistochemical localization of serotonin transporter in normal and colchicine treated rat brain. Neuroscience Research 1998 32 4 305 312 2-s2.0-0032428033 10.1016/S0168-0102(98)00097-2 (Pubitemid 29038058)
72. Qian Y., Melikian H. E., Rye D. B., Levey A. I., Blakely R. D., Identification and characterization of antidepressant-sensitive serotonin transporter proteins using site-specific antibodies. Journal of Neuroscience 1995 15 2 1261 1274 2-s2.0-0028950155
73. Murphy D. L., Fox M. A., Timpano K. R., Moya P. R., Ren-Patterson R., Andrews A. M., Holmes A., Lesch K. P., Wendland J. R., How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems. Neuropharmacology 2008 55 6 932 960 2-s2.0-53649090041 10.1016/j.neuropharm.2008.08.034
74. Dave V., Mullaney K. J., Goderie S., Kimelberg H. K., Aschner M., Astrocytes as mediators of methylmercury neurotoxicity: effects on D-aspartate and serotonin uptake. Developmental Neuroscience 1994 16 3-4 222 231 2-s2.0-0028606987
75. Bel N., Figueras G., Vilaró M. T., Suñol C., Artigas F., Antidepressant drugs inhibit a glial 5-hydroxytryptamine transporter in rat brain. European Journal of Neuroscience 1997 9 8 1728 1738 2-s2.0-0030839236 10.1111/j.1460-9568.1997.tb01530.x (Pubitemid 27348331)
76. Kubota N., Kiuchi Y., Nemoto M., Oyamada H., Ohno M., Funahashi H., Shioda S., Oguchi K., Regulation of serotonin transporter gene expression in human glial cells by growth factors. European Journal of Pharmacology 2001 417 1-2 69 76 2-s2.0-0035815270 10.1016/S0014-2999(01)00906-2 (Pubitemid 32299870)
77. Inazu M., Takeda H., Ikoshi H., Sugisawa M., Uchida Y., Matsumiya T., Pharmacological characterization and visualization of the glial serotonin transporter. Neurochemistry International 2001 39 1 39 49 2-s2.0-0035049131 10.1016/S0197-0186(01)00010-9 (Pubitemid 32304454)
78. Horikawa H., Kato T. A., Mizoguchi Y., Monji A., Seki Y., Ohkuri T., Gotoh L., Yonaha M., Ueda T., Hashioka S., Kanba S., Inhibitory effects of SSRIs on IFN- γ induced microglial activation through the regulation of intracellular calcium. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2010 34 7 1306 1316 2-s2.0-77956421517 10.1016/j.pnpbp.2010.07.015
79. Vannucci R. C., Lyons D. T., Vasta F., Regional cerebral blood flow during hypoxia-ischemia in immature rats. Stroke 1988 19 2 245 250 2-s2.0-0023871593 (Pubitemid 18084400)
80. Choi D. W., Excitotoxicity, apoptosis, and ischemic stroke. Journal of Biochemistry and Molecular Biology 2001 34 1 8 14 2-s2.0-0035581688
81. Wayenberg J. L., Ransy V., Vermeylen D., Damis E., Bottari S. P., Nitrated plasma albumin as a marker of nitrative stress and neonatal encephalopathy in perinatal asphyxia. Free Radical Biology and Medicine 2009 47 7 975 982 2-s2.0-69349084302 10.1016/j.freeradbiomed.2009.07.003
82. Buonocore G., Groenendaal F., Anti-oxidant strategies. Seminars in Fetal and Neonatal Medicine 2007 12 4 287 295 2-s2.0-34249882176 10.1016/j.siny.2007. 01.020 (Pubitemid 46875057)
83. Arvin K. L., Han B. H., Du Y., Lin S. Z., Paul S. M., Holtzman D. M., Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury. Annals of Neurology 2002 52 1 54 61 2-s2.0-0036289498 10.1002/ana.10242 (Pubitemid 34693743)
84. Cai Z., Lin S., Fan L. W., Pang Y., Rhodes P. G., Minocycline alleviates hypoxic-ischemic injury to developing oligodendrocytes in the neonatal rat brain. Neuroscience 2006 137 2 425 435 2-s2.0-29744434032 10.1016/j. neuroscience.2005.09.023 (Pubitemid 43031509)
85. Kremlev S. G., Roberts R. L., Palmer C., Minocycline modulates chemokine receptors but not interleukin-10 mRNA expression in hypoxic-ischemic neonatal rat brain. Journal of Neuroscience Research 2007 85 11 2450 2459 2-s2.0-34547640300 10.1002/jnr.21380 (Pubitemid 47204759)
86. Toti P., paolot@unisi.it De Felice C., Schürfeld K., Stumpo M., Bartolommei S., Lombardi A., Petraglia F., Buonocore G., Cyclooxygenase-2 immunoreactivity in the ischemic neonatal human brain: an autopsy study. Journal of Submicroscopic Cytology and Pathology 2001 33 3 245 249 (Pubitemid 33759999)
87. Yin W., Signore A. P., Iwai M., Cao G., Gao Y., Johnnides M. J., Hickey R. W., Chen J., Preconditioning suppresses inflammation in neonatal hypoxic ischemia via Akt activation. Stroke 2007 38 3 1017 1024 2-s2.0-33947494524 10.1161/01.STR.0000258102.18836.ca (Pubitemid 46568468)
88. Šumanović-Glamuzina D., dara.glamuzina@tel.net.ba Čulo F., Čulo M.-I., Konjevoda P., Božić T., Robović A., Vukšić I., Bilinovac Ž., Kuzman Z., Vasodilatory prostaglandins in perinatal hypoxic brain damage. Collegium Antropologicum 2008 32 183 187
89. Bona E., Andersson A. L., Blomgren K., Gilland E., Puka-Sundvall M., Gustafson K., Hagberg H., Chemokine and inflammatory cell response to hypoxia-ischemia in immature rats. Pediatric Research 1999 45 4 500 509 2-s2.0-0032940020 (Pubitemid 29162729)
90. Girard S., Sébire G., Guillaume.Sebire@usherbrooke.ca Kadhim H., Proinflammatory orientation of the interleukin 1 system and downstream induction of matrix metalloproteinase 9 in the pathophysiology of human perinatal white matter damage. Journal of Neuropathology and Experimental Neurology 2010 69 11 1116 1129 10.1097/NEN.0b013e3181f971e4
91. Kadhim H., Tabarki B., Verellen G., De Prez C., Rona A. M., Sébire G., Inflammatory cytokines in the pathogenesis of periventricular leukomalacia. Neurology 2001 56 10 1278 1284 2-s2.0-0035933039 (Pubitemid 32455283)
92. Vela J. M., Molina-Holgado E., Arévalo-Martín Á., Almazán G., Guaza C., Interleukin-1 regulates proliferation and differentiation of oligodendrocyte progenitor cells. Molecular and Cellular Neuroscience 2002 20 3 489 502 2-s2.0-0036353262 10.1006/mcne.2002.1127 (Pubitemid 34971563)
93. Dringen R., Gebhardt R., Hamprecht B., Glycogen in astrocytes: possible function as lactate supply for neighboring cells. Brain Research 1993 623 2 208 214 2-s2.0-0027216810 10.1016/0006-8993(93)91429-V (Pubitemid 23275402)
94. Wilson J. X., Antioxidant defense of the brain: a role for astrocytes. Canadian Journal of Physiology and Pharmacology 1997 75 10-11 1149 1163 2-s2.0-0031465419 10.1139/cjpp-75-10-11-1149 (Pubitemid 28033933)
95. Järlestedt K., Rousset C. I., Faiz M., Wilhelmsson U., Stahlberg A., Sourkova H., Pekna M., Mallard C., Hagberg H., Pekny M., Attenuation of reactive gliosis does not affect infarct volume in neonatal hypoxic-ischemic brain injury in mice. PLoS ONE 2010 5 4 2-s2.0-77956403252 10.1371/journal.pone. 0010397 e10397
96. Jin Y., Silverman A. J., Vannucci S. J., Mast cells are early responders after hypoxia-ischemia in immature rat brain. Stroke 2009 40 9 3107 3112 2-s2.0-70349237576 10.1161/STROKEAHA.109.549691
97. Brochu M.-E., Marie-Elsa.Brochu@USherbrooke.ca Girard S., Sylvie.Girard@USherbrooke.ca Lavoie K., Karine.Lavoie2@USherbrooke.ca Sébire G., Guillaume.Sebire@USherbrooke.ca Developmental regulation of the neuroinflammatory responses to LPS and/or hypoxia-ischemia between preterm and term neonates: an experimental study. Journal of Neuroinflammation 2011 20 55 69 10.1186/1742-2094-8-55
98. Huh Y., Jung J. W., Park C., Ryu J. R., Shin C. Y., Kim W. K., Ryu J. H., Microglial activation and tyrosine hydroxylase immunoreactivity in the substantia nigral region following transient focal ischemia in rats. Neuroscience Letters 2003 349 1 63 67 2-s2.0-0142011572 10.1016/S0304-3940(03) 00743-2 (Pubitemid 37289271)
99. Bhat R. V., DiRocco R., Marcy V. R., Flood D. G., Zhu Y., Dobrzanski P., Siman R., Scott R., Contreras P. C., Miller M., Increased expression of IL-1 β converting enzyme in hippocampus after ischemia: selective localization in microglia. Journal of Neuroscience 1996 16 13 4146 4154 2-s2.0-8944259908 (Pubitemid 26192410)
100. Silveira R. C., Procianoy R. S., Interleukin-6 and tumour necrosis factor-a levels in plasma and cerebral spinal fluid of term newborn infants with hypoxic-ischemic encephalopathy. Journal of Pediatrics 2003 143 625 629 (Pubitemid 37452790)
101. Davalos D., Grutzendler J., Yang G., Kim J. V., Zuo Y., Jung S., Littman D. R., Dustin M. L., Gan W. B., ATP mediates rapid microglial response to local brain injury in vivo. Nature Neuroscience 2005 8 6 752 758 2-s2.0-22244464662 10.1038/nn1472 (Pubitemid 43085841)
102. Raivich G., Like cops on the beat: the active role of resting microglia. Trends in Neurosciences 2005 28 11 571 573 2-s2.0-26944453586 10.1016/j.tins.2005.09.001 (Pubitemid 41476686)
103. Kettenmann H., Neuroscience: the brain's garbage men. Nature 2007 446 7139 987 989 2-s2.0-34247610848 10.1038/nature05713 (Pubitemid 46676052)
104. Ivacko J. A., Sun R., Silverstein F. S., Hypoxic-ischemic brain injury induces an acute microglial reaction in perinatal rats. Pediatric Research 1996 39 1 39 47 2-s2.0-0030046685 (Pubitemid 26003520)
105. McRae A., Gilland E., Bona E., Hagberg H., Microglia activation after neonatal hypoxic-ischemia. Developmental Brain Research 1995 84 2 245 252 2-s2.0-0028854649 10.1016/0165-3806(94)00177-2
106. Biran V., Joly L.-M., Héron A., Vernet A., Véga C., Mariani J., Renolleau S., Charriaut-Marlangue C., Christiane.Marlangue@snv.jussieu.fr Glial activation in white matter following ischemia in the neonatal P7 rat brain. Experimental Neurology 2006 199 1 103 112 10.1016/j.expneurol.2006.01.037
107. Basu A., Lazovic J., Krady J. K., Mauger D. T., Rothstein R. P., Smith M. B., Levison S. W., Interleukin-1 and the interleukin-1 type 1 receptor are essential for the progressive neurodegeneration that ensues subsequent to a mild hypoxic/ischemic injury. Journal of Cerebral Blood Flow and Metabolism 2005 25 1 17 29 2-s2.0-11844254511 10.1038/sj.jcbfm.9600002 (Pubitemid 40096894)
108. Bartha A. I., Miller S. P., Foster-Barber A., Vigneron D. B., Glidden D. V., Barkovich A. J., Ferriero D. M., Cytokines are associated with cerebral metabolism and outcome in term neonatal encephalopathy. Developmental Neuroscience 2005 27, article 270
109. 4R expression after hypoxia-ischemia is associated with microglia in the immature rat brain. Journal of Neuroimmunology 2009 212 1-2 35 43 2-s2.0-67649884746 10.1016/j.jneuroim.2009.04.016
110. Amin A. R., Attur M. G., Thakker G. D., Patel P. D., Vyas P. R., Patel R. N., Patel I. R., Abramson S. B., A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. Proceedings of the National Academy of Sciences of the United States of America 1996 93 24 14014 14019 2-s2.0-0030450402 10.1073/pnas.93.24.14014 (Pubitemid 26424237)
111. Yrjänheikki J., Keinänen R., Pellikka M., Hökfelt T., Koistinaho J., jari.koistinaho@uku.fi Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proceedings of the National Academy of Sciences of the United States of America 1998 95 26 15769 15774 10.1073/pnas.95.26.15769 (Pubitemid 29018775)
112. Yrjänheikki J., Tikka T., Keinänen R., Goldsteins G., Chan P. H., Koistinaho J., jari.koistinaho@uku.fi A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proceedings of the National Academy of Sciences of the United States of America 1999 96 23 13496 13500 10.1073/pnas.96.23.13496
113. Brogden R. N., Speight T. M., Avery G. S., Minocycline: a review of its antibacterial and pharmacokinetic properties and therapeutic use. Drugs 1975 9 4 251 291 2-s2.0-0016680814
114. Macdonald H., Kelly R. G., Allen E. S., Pharmacokinetic studies on minocycline in man. Clinical Pharmacology and Therapeutics 1973 14 5 852 861
115. Leonardo C. C., Eakin A. K., Ajmo J. M., Collier L. A., Pennypacker K. R., Strongin A. Y., Gottschall P. E., Delayed administration of a matrix metalloproteinase inhibitor limits progressive brain injury after hypoxia-ischemia in the neonatal rat. Journal of Neuroinflammation 2008 5 34 45 2-s2.0-51249109893 10.1186/1742-2094-5-34
116. Lechpammer M., Manning S. M., Samonte F., Nelligan J., Sabo E., Talos D. M., Volpe J. J., Jensen F. E., Minocycline treatment following hypoxic/ischaemic injury attenuates white matter injury in a rodent model of periventricular leucomalacia. Neuropathology and Applied Neurobiology 2008 34 4 379 393 10.1111/j.1365-2990.2007.00925.x
117. Ahuja M., Bishnoi M., Chopra K., Protective effect of minocycline, a semi-synthetic second-generation tetracycline against 3-nitropropionic acid (3-NP)-induced neurotoxicity. Toxicology 2008 244 2-3 111 122 2-s2.0-38749087581 10.1016/j.tox.2007.11.003
118. Zhang L., Shirayama Y., Shimizu E., Iyo M., Hashimoto K., Protective effects of minocycline on 3,4-methylenedioxymethamphetamine-induced neurotoxicity in serotonergic and dopaminergic neurons of mouse brain. European Journal of Pharmacology 2006 544 13 1 9 2-s2.0-33746635469 10.1016/j.ejphar. 2006.05.047 (Pubitemid 44148565)
119. Zabad R. K., Metz L. M., Todoruk T. R., Zhang Y., Mitchell J. R., Yeung M., Patry D. G., Bell R. B., Yong V. W., The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study. Multiple Sclerosis 2007 13 4 517 526 2-s2.0-34249039892 10.1177/1352458506070319 (Pubitemid 46796512)
120. Lampl Y., Boaz M., Gilad R., Lorberboym M., Dabby R., Rapoport A., Anca-Hershkowitz M., Sadeh M., Minocycline treatment in acute stroke: an open-label, evaluator-blinded study. Neurology 2007 69 14 1404 1410 2-s2.0-34848857092 10.1212/01.wnl.0000277487.04281.db (Pubitemid 47511461)
121. Griffin M. O., Fricovsky E., Ceballos G., Villarreal F., Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literature. American Journal of Physiology 2010 299 3 C539 C548 2-s2.0-77956562826 10.1152/ajpcell.00047.2010
122. Plane J. M., Shen Y., Pleasure D. E., Deng W., Prospects for minocycline neuroprotection. Archives of Neurology 2010 67 12 1442 1448 2-s2.0-78650132056 10.1001/archneurol.2010.191
123. Buller K. M., Carty M. L., Reinebrant H. E., Wixey J. A., Minocycline: a neuroprotective agent for hypoxic-ischemic brain injury in the neonate? Journal of Neuroscience Research 2009 87 3 599 608 2-s2.0-62849106987 10.1002/jnr.21890
124. Laurence D. R., Bennett P. N., Clinical Pharmacology 1987 6th New York, NY, USA Churchill Livingstone
125. Hardman J. G., Limbird L. E., Goodman and Gilman's the Pharmacological Basis of Therapeutics 1996 9th New York, NY, USA The Mcgraw-Hill Companies
126. Cascio A., acascio@unime.it Di Liberto C., D'Angelo M., Iaria C., Scarlata F., Titone L., Campisi G., No findings of dental defects in children treated with minocycline. Antimicrobial Agents and Chemotherapy 2004 48 7 2739
127. Geiger A. S., Rice A. C., Shapiro S. M., Minocycline blocks acute bilirubin-induced neurological dysfunction in jaundiced Gunn rats. Neonatology 2007 92 4 219 226 2-s2.0-36248932681 10.1159/000103740 (Pubitemid 350125278)
128. Lin S., Wei X., Bales K. R., Paul A. B. C., Ma Z., Yan G., Paul S. M., Du Y., Minocycline blocks bilirubin neurotoxicity and prevents hyperbilirubinemia-induced cerebellar hypoplasia in the Gunn rat. European Journal of Neuroscience 2005 22 1 21 27 2-s2.0-23044460297 10.1111/j.1460-9568. 2005.04182.x (Pubitemid 41059968)
129. Shapiro S. M., Bhutani V. K., Johnson L., Hyperbilirubinemia and kernicterus. Clinics in Perinatology 2006 33 2 387 410 2-s2.0-33744911082 10.1016/j.clp.2006.03.010 (Pubitemid 43841897)
130. Aranda J. V., Thomas R., Systematic review: intravenous ibuprofen in preterm newborns. Seminars in Perinatology 2006 30 3 114 120 2-s2.0-33745248045 10.1053/j.semperi.2006.04.003 (Pubitemid 43928131)
131. Varvarigou A., Bardin C. L., Beharry K., Chemtob S., Papageorgiou A., Aranda J. V., Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants. Journal of the American Medical Association 1996 275 7 539 544 2-s2.0-0030027438 10.1001/jama.275.7.539 (Pubitemid 26061429)
132. Parepally J. M. R., Mandula H., Smith Q. R., Brain uptake of nonsteroidal anti-inflammatory drugs: ibuprofen, flurbiprofen, and indomethacin. Pharmaceutical Research 2006 23 5 873 881 2-s2.0-33646891527 10.1007/s11095-006-9905-5 (Pubitemid 43781395)
133. Park E. M., Cho B. P., Volpe B. T., Cruz M. O., Joh T. H., Cho S., Ibuprofen protects ischemia-induced neuronal injury via up-regulating interleukin-1 receptor antagonist expression. Neuroscience 2005 132 3 625 631 2-s2.0-17044389797 10.1016/j.neuroscience.2005.01.021
134. Antezana D. F., Clatterbuck R. E., Alkayed N. J., Murphy S. J., Anderson L. G., Frazier J., Hurn P. D., Traystman R. J., Tamargo R. J., High-dose ibuprofen for reduction of striatal infarcts during middle cerebral artery occlusion in rats. Journal of Neurosurgery 2003 98 4 860 866 2-s2.0-0037380273 (Pubitemid 36396790)
135. Patel P. M., Drummon J. C., Sano T., Cole D. J., Kalkman C. J., Yaksh T. L., Effect of ibuprofen on regional eicosanoid production and neuronal injury after forebrain ischemia in rats. Brain Research 1993 614 1-2 315 324 2-s2.0-0027319385 (Pubitemid 23181184)
136. Cole D. J., Patel P. M., Reynolds L., Drummond J. C., Marcantonio S., Temporary focal cerebral ischemia in spontaneously hypertensive rats: the effect of ibuprofen on infarct volume. Journal of Pharmacology and Experimental Therapeutics 1993 266 3 1713 1717 2-s2.0-0027819298 (Pubitemid 24175826)
137. Miller S. P., Mayer E. E., Clyman R. I., Glidden D. V., Hamrick S. E. G., Barkovich A. J., Prolonged indomethacin exposure is associated with decreased white matter injury detected with magnetic resonance imaging in premature newborns at 24 to 28 weeks' gestation at birth. Pediatrics 2006 117 5 1626 1631 2-s2.0-33646835373 10.1542/peds.2005-1767 (Pubitemid 46071389)
138. Aly H., Abd-Rabboh L., El-Dib M., Nawwar F., Hassan H., Aaref M., Abdelrahman S., Elsayed A., Ascorbic acid combined with ibuprofen in hypoxic ischemic encephalopathy: a randomized controlled trial. Journal of Perinatology 2009 29 6 438 443 2-s2.0-67349096792 10.1038/jp.2009.1
139. Lim G. P., Yang F., Chu T., Chen P., Beech W., Teter B., Tran T., Ubeda O., Ashe K. H., Frautschy S. A., Cole G. M., Ibuprofen suppresses plaque pathology and inflammation in a mouse model for alzheimer's disease. Journal of Neuroscience 2000 20 15 5709 5714 2-s2.0-0034254924 (Pubitemid 30636898)
140. Yokota C., Kaji T., Kuge Y., Inoue H., Tamaki N., Minematsu K., Temporal and topographic profiles of cyclooxygenase-2 expression during 24 h of focal brain ischemia in rats. Neuroscience Letters 2004 357 3 219 222 2-s2.0-1542315515 10.1016/j.neulet.2003.12.109 (Pubitemid 38299262)
141. Candelario-Jalil E., Fiebich B. L., Cyclooxygenase inhibition in ischemic brain injury. Current Pharmaceutical Design 2008 14 14 1401 1418 2-s2.0-47249106478 10.2174/138161208784480216 (Pubitemid 351982548)
142. Fathali N., Ostrowski R. P., Lekic T., Jadhav V., Tong W., Tang J., Zhang J. H., Cyclooxygenase-2 inhibition provides lasting protection against neonatal hypoxic-ischemic brain injury. Critical Care Medicine 2010 38 2 572 578 2-s2.0-74949139083 10.1097/CCM.0b013e3181cb1158
143. Carty M. L., Wixey J. A., Reinebrant H. E., Gobe G., Colditz P. B., Buller K. M., k.buller@uq.edu.au Ibuprofen inhibits neuroinflammation and attenuates white matter damage following hypoxia-ischemia in the immature rodent brain. Brain Research 2011 1402 9 19 10.1016/j.brainres.2011.06.001
144. Taskin E., Ozcan K., Canacankatan N., Satar M., Yapcolu H., Erdoan Ş., The effects of indomethacin on caspases, glutathione level and lipid peroxidation in the newborn rats with hypoxic-ischemic cerebral injury. Brain Research 2009 1289 118 123 2-s2.0-68649095940 10.1016/j.brainres.2009.07.010
145. Tutak E., Satar M., Zorludemir S., Erdoan Ş., Yapcolu H., Narl N., Neuroprotective effects of indomethacin and aminoguanidine in the newborn rats with hypoxic-ischemic cerebral injury. Neurochemical Research 2005 30 8 937 942 2-s2.0-27644518670 10.1007/s11064-005-5978-5 (Pubitemid 41570027)
146. Cheng Y., Deshmukh M., D'Costa A., Demaro J. A., Gidday J. M., Shah A., Sun Y., Jacquin M. F., Johnson E. M., Holtzman D. M., Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury. Journal of Clinical Investigation 1998 101 9 1992 1999 2-s2.0-0032080673 (Pubitemid 28226119)
147. Dihné M., Grommes C., Lutzenburg M., Witte O. W., Block F., Different mechanisms of secondary neuronal damage in thalamic nuclei after focal cerebral ischemia in rats. Stroke 2002 33 12 3006 3011 2-s2.0-0036903442 10.1161/01.STR.0000039406.64644.CB (Pubitemid 35462879)
148. Tokuno T., Kataoka K., Asai T., Chichibu S., Kuroda R., Ioku M., Yamada K., Hayakawa T., Functional changes in thalamic relay neurons after focal cerebral infarct: a study of unit recordings from VPL neurons after MCA occlusion in rats. Journal of Cerebral Blood Flow and Metabolism 1992 12 6 954 961 2-s2.0-0026778665
149. Banati R. B., Cagnin A., Brooks D. J., Gunn R. N., Myers R., Jones T., Birch R., Anand P., Long-term trans-synaptic glial responses in the human thalamus after peripheral nerve injury. Neuroreport 2001 12 16 3439 3442 2-s2.0-0035900348 (Pubitemid 33065473)
150. Cho B. P., Song D. Y., Sugama S., Shin D. H., Shimizu Y., Kim S. S., Kim Y. S., Joh T. H., Pathological dynamics of activated microglia following medial forebrain bundle transection. GLIA 2006 53 1 92 102 2-s2.0-30444435621 10.1002/glia.20265 (Pubitemid 43076216)
151. Block F., fblock@ukaachen.de Dihné M., Loos M., Inflammation in areas of remote changes following focal brain lesion. Progress in Neurobiology 2005 75 5 342 365 10.1016/j.pneurobio.2005.03.004 (Pubitemid 40733269)
152. Marlow N., Rose A. S., Rands C. E., Draper E. S., Neuropyschological and educational problems at school age associated with neonatal encephalopathy. Archives of Disease in Childhood 2005 90 380 387
153. Paterson D. S., Belliveau R. A., Trachtenberg F., Kinney H. C., Differential development of 5-HT receptor and the serotonin transporter binding in the human infant medulla. Journal of Comparative Neurology 2004 472 2 221 231 2-s2.0-1842615115 10.1002/cne.20105 (Pubitemid 38429022)
154. Paterson D. S., Trachtenberg F. L., Thompson E. G., Belliveau R. A., Beggs A. H., Darnall R., Chadwick A. E., Krous H. F., Kinney H. C., Multiple serotonergic brainstem abnormalities in sudden infant death syndrome. Journal of the American Medical Association 2006 296 17 2124 2132 2-s2.0-33750518186 10.1001/jama.296.17.2124 (Pubitemid 44664707)
155. Kinney H. C., Richerson G. B., Dymecki S. M., Darnall R. A., Nattie E. E., The brainstem and serotonin in the sudden infant death syndrome. Annual Review of Pathology: Mechanisms of Disease 2009 4 517 550 2-s2.0-66149091961 10.1146/annurev.pathol.4.110807.092322
156. Malloy M. H., Hoffman H. J., Prematurity, sudden infant death syndrome, and age of death. Pediatrics 1995 96 3 464 471 2-s2.0-0029086298
157. Tarazi F. I., Tomasini E. C., Baldessarini R. J., Postnatal development of dopamine and serotonin transporters in rat caudate-putamen and nucleus accumbens septi. Neuroscience Letters 1998 254 1 21 24 2-s2.0-0032544548 10.1016/S0304-3940(98)00644-2 (Pubitemid 28430615)
158. Moll G. H., Mehnert C., Wicker M., Bock N., Rothenberger A., Rüther E., Huether G., Age-associated changes in the densities of presynaptic monoamine transporters in different regions of the rat brain from early juvenile life to late adulthood. Developmental Brain Research 2000 119 2 251 257 2-s2.0-0033954391 10.1016/S0165-3806(99)00182-0 (Pubitemid 30089816)
159. Galineau L., Kodas E., Guilloteau D., Vilar M. P., Chalon S., Ontogeny of the dopamine and serotonin transporters in the rat brain: an autoradiographic study. Neuroscience Letters 2004 363 3 266 271 2-s2.0-2942618756 10.1016/j.neulet.2004.04.007 (Pubitemid 38746526)
160. Zhou F. C., Azmitia E. C., Bledsoe S., Rapid serotonergic fiber sprouting in response to ibotenic acid lesion in the striatum and hippocampus. Developmental Brain Research 1995 84 1 89 98 2-s2.0-0028888758 10.1016/0165-3806(94)00158-V
161. Inman D. M., Steward O., Ascending sensory, but not other long-tract axons, regenerate into the connective tissue matrix that forms at the site of a spinal cord injury in mice. Journal of Comparative Neurology 2003 462 4 431 449 2-s2.0-0038460895 10.1002/cne.10768 (Pubitemid 36775904)
162. Hawthorne A. L., Hu H., Kundu B., Steinmetz M. P., Wylie C. J., Deneris E. S., Silver J., jxs10@cwru.edu The unusual response of serotonergic neurons after CNS injury: lack of axonal dieback and enhanced sprouting within the inhibitory environment of the glial scar. Journal of Neuroscience 2011 31 15 5605 5616 10.1523/JNEUROSCI.6663-10.2011
163. Guo G., Bhat N. R., p38 α MAP kinase mediates hypoxia-induced motor neuron cell death: a potential target of minocycline's neuroprotective action. Neurochemical Research 2007 32 12 2160 2166 2-s2.0-35848946825 10.1007/s11064-007-9408-8 (Pubitemid 350059860)
164. Fan L. W., Lin S., Pang Y., Rhodes P. G., Cai Z., Minocycline attenuates hypoxia-ischemia-induced neurological dysfunction and brain injury in the juvenile rat. European Journal of Neuroscience 2006 24 2 341 350 2-s2.0-33746254939 10.1111/j.1460-9568.2006.04918.x (Pubitemid 44100326)
165. Matsukawa N., Yasuhara T., Hara K., Xu L., Maki M., Yu G., Kaneko Y., Ojika K., Hess D. C., Borlongan C. V., Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic stroke. BMC Neuroscience 2009 10, article 1471 126 2-s2.0-70449507674 10.1186/1471-2202-10-126